Kidney Transplant Failure
23
1
6
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
1 terminated out of 23 trials
88.9%
+2.3% vs benchmark
9%
2 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (23)
Plant-based Diet for Kidney Transplant Recipients
Investigating the Impact of AI on Shared Decision Making in Post-kidney Transplant Care
Observational Cohort Study Renal Transplantation University Hospitals Leuven
Dapagliflozin in Living-Donor Kidney Transplant Recipients
The smartNTx Trial:Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR)
HLA Eplet Mismatches to Predict Long-term Kidney Transplant Outcomes
Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation
Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?
Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
Prevent Allosensitization in Patients Who Have Failed a First Renal Transplant (PART)
Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection
Aortoiliac Stenosis in Kidney Transplantation
Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes?
A Clinical Practice Snapshot on Pediatric Kidney Transplantation
Immunosuppression Reduction in Failed Allograft Guided by cfDNA
Protocol Biopsies in High-risk Renal Transplant Recipients
Human Versus Computer-based Predictions of Long Allograft Survival
SURGICAL EXPERIENCE ON RENAL TRANSPLANT COMPLICATIONS
Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
Kidney Transplantation and Renal and Myocardial Perfusion